Carbamazepine Tablets — Class II drug recall D-0365-2022
Terminated recall by Torrent Pharma Inc., reported 2022-01-19, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0365-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharma Inc., Basking Ridge, NJ, United States |
| Recall initiated | 2021-12-02 |
| Classified | 2022-01-11 |
| Reported by FDA | 2022-01-19 |
| Terminated | 2023-10-23 |
| Distributed | Nationwide (US) |
| Quantity | 15,336 bottles |
| Reason classes | specification failure |
| NDC | 13668-0268, 13668-0268-01, 13668-0268-05, 13668-0268-10, 13668-0268-30, 13668-0268-31, 13668-0271, 13668-0271-01, 13668-0271-05, 13668-0271-10, 13668-0271-49 |
| Lot numbers | 4J11G002 |
| Expiration dates | 2024-08 |
Product
Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd. Bharuch-392130, India Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920.
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0365-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.